Co-founder and Chief Executive Officer
I am a Science Entrepreneur with a background in Biochemistry and Diagnostics. My main interest is to develop healthcare academic research into impact innovations. My current focus includes diagnostics applications for large patient populations and therapeutics solutions for low and middle income countries. My free time is generally spent exploring the great outdoors.
Cambridge (UK), Jan 2018 – current. Cambridge Judge Business School: Start and development of life science venture. Business development. Market research.
Cambridge (UK), Nov 2017 – current. POCKiT diagnostics Ltd: Creation and development of a novel diagnostic tool for stroke patient triage. Fundraising. IP development. Supervision of PhD students.
Cambridge (UK), Feb 2018 – Oct 2018. Owlstone Medical Ltd: Ideation and Clinical testing of a breath test for lung cancer screening.
Israel, Apr 2014 – Jun 2014. Eytan Ruppin’s Laboratory. Genome-scale metabolic modeling of cancer.
Cambridge (UK), Sep 2012 – Sep 2014. Hutchison/MRC Research Centre, Cancer Unit - Dr C. Frezza lab: Investigation of altered metabolism in several diseases. Discovery of metabolic markers for disease diagnosis. Understanding metabolic liabilities of cancer for novel therapeutic applications.
Cambridge (UK), Oct 2014 – Dec 2017. University of Cambridge - Hutchison/MRC Research Centre, Cancer Unit - Dr C. Frezza lab: Investigation of altered mitochondrial metabolism in cancer initiation and progression. Discovery of alternative mitochondrial therapeutics in cancer.
Milan (Italy), Oct 2009 – Mar 2012. Vita-Salute San Raffaele University - Medical Biotechnology program: Metabolomics investigation of neural stem cells phenotype. Focus on the development and maintenance of R-software package for metabolomics bioinformatics data analysis. Full grades (110/110).
Milan (Italy), Oct 2006 – Sep 2009. Vita-Salute San Raffaele University - Medical Biotechnology program: Full grades (107/110).
1 First (co-) author. Sorted by date of publication\